Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people on Wegovy do notice a change in their breath, particularly in the first weeks of treatment. It is not listed as a named side effect in the semaglutide Patient Information Leaflet, but there are two biological reasons it can happen, and both are manageable. This is a licensed prescription treatment for weight management that changes how your digestive system works, so a handful of unexpected body changes during the first month or two are not unusual — breath being one that catches people off guard.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide slows the rate at which your stomach empties food into the small intestine. That is part of how it reduces appetite, food stays with you longer, so hunger signals come less often. The flip side is that fermentation of partially digested food can produce sulphurous gases that make their way upward. Burping is a listed side effect in the NHS semaglutide medicines page, and when that gas carries odour, breath is the first place you notice it.
There is a second, often overlooked reason. When your calorie intake drops sharply, especially if carbohydrate intake falls too, your body may begin producing ketones as an alternative fuel. Ketones have a distinctive sweet-but-sharp smell that comes through the breath. It is the same phenomenon people report on very low-carb diets. It does not mean anything is wrong (it is your body responding to a genuine energy deficit) but it can be socially noticeable.
Finally, drinking less is common early on because appetite suppression often reduces thirst cues too. Less fluid means less saliva, and reduced saliva allows odour-causing bacteria to build up faster. Worth checking: are you drinking enough water across the day? Our page on what to eat on Wegovy covers hydration alongside food choices in more detail.
Largely, yes. The ketone-related breath that some Wegovy users notice shares its chemistry with the breath changes people get on ketogenic diets. It is not caused by the semaglutide molecule itself, it is caused by what the medicine does: reducing how much you eat, which can shift your metabolism toward fat-burning.
The clinical trial populations studied in the STEP 1 trial, published in the New England Journal of Medicine, consistently reported gastrointestinal effects as the most common side-effect category. Breath odour specifically was not tracked as a separate outcome, but the underlying mechanisms (slower gastric emptying, reduced intake, increased fat oxidation) are all well-documented. You can read more about the appetite changes themselves on our page exploring how Wegovy affects appetite.
If you are concerned that the smell is very strong, persistent beyond the first month or two, or accompanied by other symptoms such as stomach pain, vomiting you cannot manage, or changes in urine colour, those are worth raising with your prescriber. Severe or persistent stomach pain that radiates to the back should be assessed urgently, as the MHRA issued specific guidance in January 2026 flagging acute pancreatitis as an infrequent but serious risk with GLP-1 medicines, always report anything that worries you via the MHRA Yellow Card scheme.
For most people, yes. The first four to eight weeks on Wegovy are when your body is adjusting to a slower digestive pace and a lower calorie load. As intake stabilises at a level that your body has adapted to, the acute ketone production tends to reduce. The burping that drives odour upward also tends to become less frequent as your digestive system settles.
If you are still in the titration phase (moving through lower doses toward the maintenance dose) the smell may temporarily worsen around each step up. That is normal and usually brief. People who find this phase difficult often describe feeling slightly embarrassed about it, which is completely understandable. It is one of those unglamorous realities that gets left out of most treatment write-ups. It does not mean the medicine is failing or that you are doing something wrong.
The practical steps that help most: drink water consistently through the day rather than in large bursts, eat regular small meals rather than skipping (skipping can push the body further into ketosis), include enough protein to maintain muscle and satiety, and keep up whatever oral hygiene routine works for you. Our Wegovy cost page has an overview of what a full treatment programme includes if you are still deciding whether to proceed.
Breath odour alone, mild and settling over a few weeks, does not usually need a clinical review. But it is always sensible to raise it if you have any doubt, especially if it is accompanied by other symptoms, if it starts after a period of having been fine, or if it is affecting your daily life more than you expected.
At nume, a real clinician (not a decision tree) reads your consultation. Our prescribers are on hand seven days a week for aftercare questions, so you do not have to decide alone whether something needs attention. You can also browse common questions on our FAQs page or read more background about the service and our clinical team on the about us page. Related queries we have covered: Wegovy and breath in general, and bad breath specifically while on semaglutide. If you are ready to speak to our prescribers, start your free consultation here.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.